Rebecca Bakker-Arkema

Rebecca Bakker-Arkema is a seasoned professional in clinical development and research with extensive experience spanning over three decades. As Co-Founder of BIA Clinical Group, LLC since June 2018 and Vice President of Clinical Development at LIB Therapeutics, LLC since May 2019, Rebecca has demonstrated leadership in innovative therapeutic strategies. Additionally, Rebecca founded and serves as President of Tanglewood Clinical Consulting, LLC, while previously holding significant roles including Vice President of Clinical Research at Gemphire Therapeutics and AlphaCore Pharma, and Senior Director of Clinical Development at Metabasis Therapeutics. Rebecca's early career included key roles at Pfizer and Upjohn Pharmaceutical Company. Educational background includes a degree from the University of Kansas.